Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Orphan G Protein-Coupled Receptor GPR52 is a Novel Regulator of Breast Cancer Multicellular Organization.

Autor: Hanif SZ; Weill Cornell Medicine/Rockefeller University/Memorial Sloan-Kettering Cancer Center Tri-Institutional MD-PhD Program, New York, NY, USA.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Au CC; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Torregroza I; Department of Surgery, Weill Cornell Medicine, New York, NY, USA., Jannath SY; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; Hunter College, City University of New York, New York, NY, USA., Fabiha T; Columbia University Computational & Systems Biology Program, Sloan-Kettering Institute of Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Bhinder B; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York, USA., Washburn M; Department of Cancer Biology, University of Kansas Medical Center Kansas City KS USA.; University of Kansas Cancer Center, Kansas City, KS, USA., Devost D; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada., Liu S; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Bhardwaj P; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Evans T; Department of Surgery, Weill Cornell Medicine, New York, NY, USA., Anand PK; Division of Genetic, Environmental and Inhalational Disease, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Tarran R; Division of Genetic, Environmental and Inhalational Disease, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Palikhe S; Department of Cell Biology and Physiology, University of Kansas Medical Center Kansas City, KS, USA., Elemento O; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York, USA., Dow L; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Blenis J; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Department of Pharmacology, Weill Cornell Medicine, New York, NY, USA.; Department of Biochemistry, Weill Cornell Medicine, New York, NY, USA., Hébert TE; Department of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada., Brown KA; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.; University of Kansas Cancer Center, Kansas City, KS, USA.; Department of Cell Biology and Physiology, University of Kansas Medical Center Kansas City, KS, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Jul 23. Date of Electronic Publication: 2024 Jul 23.